Great news take time to realise.
Lately, we had a series of good news, the latest being WalMart to distribute Cinnergen.
However, all this will not likely show up on the next quarterly bottom line. Last quarter ended in January, I believe, and year end in April. Cinnergen increased demand could start to show up for the last quarter, but Cinnechol, a product that will likely have most of the same distribution points as Cinnergen, will not start being distributed until April, imo, leaving the year-end still in the negative.
We should continue to see rises and dips, more occasions to accumulate.
Consider other products with huge market potential such as OraPhyte, and you can feel this company is going places.
Will everyone be patient? Probably not, but we will.
(Your money, your due diligence.)
alen |
